PARADIGM CAPITAL MANAGEMENT INC/NY - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 36 filers reported holding ETON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARADIGM CAPITAL MANAGEMENT INC/NY ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,251,000
+19.5%
300,0000.0%0.07%
+20.0%
Q2 2023$1,047,000
-9.4%
300,0000.0%0.06%
-22.1%
Q1 2023$1,155,000
+37.5%
300,0000.0%0.08%
+37.5%
Q4 2022$840,000
+33.3%
300,0000.0%0.06%
+24.4%
Q3 2022$630,000
+20.2%
300,000
+50.0%
0.04%
+25.0%
Q2 2022$524,000
+20.2%
200,000
+100.0%
0.04%
+50.0%
Q1 2022$436,000
+13.0%
100,000
+11.1%
0.02%
+41.2%
Q4 2021$386,00090,0000.02%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,040,000$32,845,0004.29%
AWM Investment Company, Inc. 971,681$7,900,0001.00%
Diametric Capital, LP 51,633$420,0000.33%
Mesirow Financial Investment Management, Inc. 1,046$8,504,0000.03%
Hood River Capital Management LLC 76,397$621,0000.02%
Westside Investment Management, Inc. 83,900$4,743,0000.01%
MML INVESTORS SERVICES, LLC 129,250$1,051,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 31,961$260,0000.01%
TWO SIGMA INVESTMENTS, LP 126,490$1,028,0000.00%
SEI INVESTMENTS CO 76,397$621,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders